NCT03076281View on ClinicalTrials.gov

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

December 3, 2018

Study Completion Date

August 31, 2020

Conditions
LarynxLIPOral CavityPharynx
Interventions
DRUG

Metformin Hydrochloride

Given orally

DRUG

Doxycycline

Given orally

DRUG

Metformin +Doxycycline

Given orally

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER